Politics
A rare healthcare issue both parties agree on: A solution to Alzheimer’s that can’t wait
The Hill·October 8, 2026·1 min read
Bipartisan legislators introduced the ASAP Act to authorize Medicare coverage for FDA-approved blood-based biomarker tests aimed at early detection of Alzheimer's and other dementias. The bill seeks to expand access to innovative diagnostics, addressing a rare healthcare issue where both parties agree on the urgency of a solution.
Read at The HillDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.